The Emergency Contraceptive Pills Market is being driven by Rise in number of initiatives to create awareness
The Emergency Contraceptive Pills Market is expected to grow at a CAGR of 4.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 258.4 million. Unintended pregnancies can arise from various circumstances, including unprotected sexual activity, contraceptive malfunctions, incorrect usage of birth control methods, and unfortunate incidents such as sexual assault. In developing countries, these unplanned pregnancies can lead to significant morbidity and mortality related to abortion and pregnancy complications. To mitigate these risks, the promotion of voluntary family planning has become a global priority, with organizations like the Asia Pacific Council on Contraception, the European Society of Cardiology, and the International Planned Parenthood Federation leading the charge. These entities are dedicated to disseminating knowledge about various contraceptive options, including emergency contraceptive pills, to ensure that individuals have access to effective means of family planning. In developed regions, over half of all couples utilize modern contraceptive methods, such as emergency contraceptive pills, to manage their family size and prevent unintended pregnancies.
Get more information on Emergency Contraceptive Pills Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
189 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
|
Market growth 2025-2029 |
USD 258.4 million |
|
Market structure |
market_structure.ucfirst |
|
YoY growth 2024-2025(%) |
4.2 |
|
Key countries |
US, China, Canada, Germany, UK, France, Japan, Italy, India, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Emergency Contraceptive market encompasses various methods for unintended pregnancy prevention, including Emergency Contraceptive Patches and Injections, Progestin-only Pills, and Combined Oral Contraceptives, all classified as Hormonal Contraceptives. Non-Hormonal options consist of Barrier Methods, Cervical Caps, and Natural Family Planning, such as Fertility Awareness. Reproductive Rights, Access to Healthcare, Health Equity, and Sexual Health Education are crucial factors influencing the market. Comprehensive Sex Education, Teen Pregnancy Prevention, and Unintended Pregnancy Reduction are key initiatives. Sexual Assault Prevention, Domestic Violence, and Sexual Harassment are significant social issues addressed by Emergency Contraceptives. Reproductive Justice, Women's Empowerment, and Gender Equality are essential components of the broader context. Ethical Considerations, Informed Consent, Patient Choice, Medical Ethics, Innovation Pipeline, Pharmaceutical Regulations, and Healthcare Policy shape the market landscape. Global Health, Developing Countries, International Health Organizations, Non-Governmental Organizations, Philanthropic Funding, and Social Impact are significant factors influencing market growth and accessibility.
The Emergency Contraceptive Pills (ECP) market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of various types of drugs, including Ulipristal Acetate, Copper IUD, and generic or non-generic versions of the Morning-After Pill, such as Plan B and Next Choice. According to Technavio, the global pharmaceuticals market size is determined by the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the growth of this market include the increasing global population aging, with the proportion of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe expected to reach a similar ratio by 2030.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
